Immunohistochemical analysis of allograft inflammation at day 21 after transplantation
| . | SR-BI+/+ bone marrow . | SR-BI−/− bone marrow . | ||
|---|---|---|---|---|
| Controls . | AdA-I . | Controls . | AdA-I . | |
| Leukocytes | 59 ± 3.2 | 42 ± 3.2* | 56 ± 2.6† | 63 ± 3.7‡ |
| Macrophages | 51 ± 3.7 | 33 ± 3.1* | 53 ± 3.8§ | 48 ± 4.0† |
| T lymphocytes | 10 ± 1.3 | 8.0 ± 1.2 | 7.1 ± 0.93 | 8.1 ± 2.1 |
| . | SR-BI+/+ bone marrow . | SR-BI−/− bone marrow . | ||
|---|---|---|---|---|
| Controls . | AdA-I . | Controls . | AdA-I . | |
| Leukocytes | 59 ± 3.2 | 42 ± 3.2* | 56 ± 2.6† | 63 ± 3.7‡ |
| Macrophages | 51 ± 3.7 | 33 ± 3.1* | 53 ± 3.8§ | 48 ± 4.0† |
| T lymphocytes | 10 ± 1.3 | 8.0 ± 1.2 | 7.1 ± 0.93 | 8.1 ± 2.1 |
Data are expressed in percentage of the total number of cells in the intimal area and represent mean ± SEM. The number of mice in each group is identical as in Table 2.
P < .01 vs SR-BI+/+ bone marrow controls.
P < .05 vs SR-BI+/+ bone marrow AdA-I.
P < .001 vs SR-BI+/+ bone marrow AdA-I.
P < .01 vs SR-BI+/+ bone marrow AdA-I.